Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Tian Zhang
Oct 21, 2023, 19:38 |
Blog
Top 5 Prostate abstracts not to miss by Tian Zhang
Tian Zhang, Associate Professor specialized in GU cancers at the UT Southwestern Medical Center, shared…
Sep 6, 2023, 00:26 |
Drugs
Tian Zhang: Thanks Alliance for Clinical Trials in Oncology for supporting -- PDIGREE is the only phase 3 metastatic kidney cancer trial w/ supplied immunotherapies currently enrolling!
Oct 2, 2024, 18:59 |
Blog
Jin Zhang: Exploring Precision Treatment in Breast Cancer and Advances in Anti-HER2 Therapy - MediaMedic
MediaMedic shared a post on LinkedIn: "2024 COMB丨Dr. Jin Zhang: Exploring Precision Treatment in Breast Cancer…
May 28, 2024, 08:56 |
Blog
Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix),…
Oct 20, 2024, 14:23 |
Blog
Maryam Lustberg at UCSD Moores Cancer Center on latest updates in breast cancer
Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital, posted on…
Sep 18, 2024, 09:18 |
Insight
34 Posts Not to Miss From ESMO24 Day 4
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 3, 2024, 14:47 |
Insight
Article of the day, September 3rd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 25, 2024, 14:05 |
Blog
Petros Grivas: Can’t wait for amazing Uromigos meeting!
Petros Grivas shared a post on X by Uromigos adding: "Can’t wait for amazing Uromigos…
Aug 19, 2024, 12:16 |
Insight
Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?
Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…
Aug 16, 2024, 14:16 |
Insight
Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…
1
2
3
4
5
All:
68
Posts:
21 - 30
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Clinical Trials That Changed the Life of Cancer Patients: Insights from the CEO of EORTC, Dr. Denis Lacombe
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube